SOPHiA GENETICS Closes $57.5 Million Public Offering
SOPHiA GENETICS has completed the closing of its previously announced underwritten public offering, raising total gross proceeds of $57.5 million before expenses, according to a press release. The offering was oversubscribed, leading the underwriters to fully exercise their option to purchase additional shares.
The company sold 12,104,900 ordinary shares at a public price of $4.75 per share. This total included 1,578,900 shares issued upon the full exercise of the underwriters’ option. All shares in the offering were sold by the company.
TD Cowen acted as the lead book running manager for the transaction. Guggenheim Securities served as book running manager, while BTIG and Craig Hallum acted as lead managers. The offering was made under an effective registration statement on Form F-3 filed with the U.S. Securities and Exchange Commission.
SOPHiA GENETICS is a health technology company that develops AI based solutions for precision medicine, including its SOPHiA DDM platform for analyzing genomic and multimodal data.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Nov 12 Octave Acquires Cerebre for Industrial AI Plant Models Nov 11 StitchStudio raises $8M for insurance AI products Nov 11 Stage 2 Capital Closes $100 Million for B2B AI Investments Nov 11 Enza Capital secures $21 million for African AI fund Nov 11 Goldman Sachs Forecasts Anthropic Revenue of $685 Billion by 2030AI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Pathos AI Raises $237 Million at $3 Billion Valuation
Sophont launches Holon-S1 to predict gene activity from pathology slides
Isomorphic Labs Seeks $5 Billion at $50 Billion Valuation
Anthropic seeks up to $64.4 billion in IPO priced at $70 to $78 a share
Switchpoint Bio raises $5.3 million for AI epigenomics platform
Daily AI Brief: the AI news that matters, in your inbox.